+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Outsourcing in Drug Discovery, 9th Edition - Product Thumbnail Image

Outsourcing in Drug Discovery, 9th Edition

  • Report
  • June 2020
  • 294 Pages
  • Global
From
United States Biotech Industry Report - Product Thumbnail Image

United States Biotech Industry Report

  • Report
  • May 2023
  • 24 Pages
  • United States
From
From
From
Pharma M&A Deals 2023 - Top Themes - Thematic Research - Product Thumbnail Image

Pharma M&A Deals 2023 - Top Themes - Thematic Research

  • Report
  • January 2024
  • 25 Pages
  • Global
From
From
Loading Indicator